Natalizumab Recruiting Phase 4 Trials for Disseminated Sclerosis Other

IndicationsStatusPurposePhase
RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT03046251Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis